Exploring the sialiome using titanium dioxide chromatography and mass spectrometry

Area of Science:

• Biochemistry
• Proteomics
• Analytical Chemistry

Background:

• Biomarker discovery relies on analyzing protein and peptide expression patterns in biofluids.
• Post-translational modifications, like glycosylation, add complexity and potential for specific disease biomarkers.
• Abnormal protein glycosylation is linked to various diseases, making the glycoproteome a key area for research.

Purpose of the Study:

• To develop a simple and highly selective strategy for purifying sialic acid-containing glycopeptides (the sialiome) from complex peptide mixtures.
• To characterize the human plasma and saliva sialiomes using this new method.
• To demonstrate the potential of this approach for biomarker discovery in disease diagnostics and monitoring.

Main Methods:

• Utilized the specific affinity of sialic acids for titanium dioxide under defined buffer conditions for selective purification.
• Employed mass spectrometry in conjunction with the purification strategy.
• Applied the method to analyze human plasma and saliva samples.

Main Results:

• Successfully purified sialic acid-containing glycopeptides from complex biological samples.
• Identified 192 glycosylation sites in the human plasma sialiome.
• Identified 97 glycosylation sites in the human saliva sialiome.

Conclusions:

• The developed titanium dioxide-based strategy offers a simple and selective approach for sialiome enrichment.
• This method facilitates the characterization of glycopeptides in complex biofluids.
• The approach holds significant potential for advancing biomarker discovery in clinical diagnostics and disease monitoring.